Stem cell research and regenerative medicine in 2014: First year of regenerative medicine in Japan

Stem Cells and Development

Volumn 23, Issue 18, 2014, Pages 2127-2128

  Okano, Hideyuki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACT; HUMAN; JAPAN; LAW; PUBLISHING; REGENERATIVE MEDICINE; REVIEW; STEM CELL RESEARCH; CELL DIFFERENTIATION; CYTOLOGY; PLURIPOTENT STEM CELL;

CELL DIFFERENTIATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; JAPAN; REGENERATIVE MEDICINE; STEM CELL RESEARCH;

EID: 84906993512     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0200     Document Type: Review

References (21)

1. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 7:663-676.
2. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 7:861-872.
3. Kamao H, M Mandai, S Okamoto, N Sakai, A Suga, SJ Sugita, JM Kiryu and M Takahashi. (2014). Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Rep 7:1-14.
4. Okano H and S Yamanaka. (2014). iPS cell technologies: significance and applications to CNS regeneration and disease. Mol Brain 7:22.
5. Mattis VB and CN Svendsen. (2011). Induced pluripotent stem cells: a new revolution for clinical neurology? Lancet Neurol 10:383-394.
6. Imaizumi Y and H Okano. (2013). Modeling human neurological disorders with induced pluripotent stem cells. J Neurochem 129:388-399.
7. Nakamura M and H Okano. (2013). Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells. Cell Res 23:70-80.
8. Okano H, M Nakamura, K Yoshida, Y Okada, O Tsuji, S Nori, E Ikeda, S Yamanaka and K Miura. (2013). Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res 112:523-533.
9. Okano H, T Yanagida and A Iriki. (2008). Introduction. Japan: its tradition and hot topics in biological sciences. Philos Trans R Soc Lond B Biol Sci 363:2067-2069.
10. Cyranoski D. (2014). Stem-cell method faces fresh questions. Nature 507:283.
11. Nagashima F, IK Suzuki, A Shitamukai, H Sakaguchi, M Iwashita, T Kobayashi, S Tone, K Toida, P Vanderhaeghen and Y Kosodo. (2014). Novel and robust transplantation reveals the acquisition of polarized processes by cortical cells derived from mouse and human pluripotent stem cells. Stem Cells Dev 23:2129-2142.
12. Zhao Y, M Matsuo-Takasaki, I Tsuboi, K Kimura, GT Salazar, T Yamashita and O Ohneda. (2014). Dual functions of hypoxia inducible factor-1α for the commitment of mouse embryonic stem cells toward a neural lineage original research report. Stem Cells Dev 23:2143-2155.
13. Egusa H, H Kayashima, J Miura, S Uraguchi, F Wang, H Okawa, JI Sasaki, M Saeki, T Matsumoto and H Yatani. (2014). Comparative analysis of mouse induced pluripotent stem cells and mesenchymal stem cells during osteogenic differentiation in vitro. Stem Cells Dev 23:2156-2169.
14. Kamon M, M Katano, K Hiraki-Kamon, T Hishida, Y Nakachi, Y Mizuno, Y Okazaki, A Suzuki, M Hirasaki, et al. (2013) Identification of Ccr4-not complex components as regulators of transition from partial to genuine induced pluripotent stem cells. Stem Cells Dev 23:2170-2179.
15. Kinehara M, S Kawamura, S Mimura, M Suga, A Hamada, M Wakabayashi, H Nikawa and MK Furue. (2014) Protein kinase C-induced early growth response protein-1 binding to SNAIL promoter in epithelial-mesenchymal transition of human embryonic stem cell. Stem Cells Dev 23:2180-2189.
16. Hara S, R Hayashi, T Soma, T Kageyama, T Duncan, M Tsujikawa and K Nishida. (2014). Identification and potential application of human corneal endothelial progenitor cells. Stem Cells Dev 23:2190-2201.
17. Tashiro K, A Nonaka, N Hirata, T Yamaguchi, H Mizuguchi and K Kawabata. (2014). Plasma elevation of vascular endothelial growth factor leads to the reduction of mouse hematopoietic and mesenchymal stem/progenitor cells in the bone marrow. Stem Cells Dev 23:2202-2210.
18. Moriyama M, H Isshi, S Ishihara, H Okura, A Ichinose, T Ozawa, A Matsuyama and T Hayakawa. (2014). Role of Notch signaling in the maintenance of human mesenchymal stem cells under hypoxic conditions. Stem Cells Dev 23:2211-2224.
19. Wada N, H Maeda, D Hasegawa, S Gronthos, PM Bartold, D Menicanin, S Fujii, S Yoshida, A Tomokiyo, S Monnouchi and A Akamine. (2014). Semaphorin 3A induces mesenchymal stem-like properties in human periodontal ligament cells. Stem Cells Dev 23:2225-2236.
20. Zheng YW, T Tsuchida, T Shimao, B Li, T Takebe, RR Zhang, Y Sakurai, Y Ueno, K Sekine, et al. (2014). The CD133 + CD44 + precancerous subpopulation of oval cells is a therapeutic target for hepatocellular carcinoma. Stem Cells Dev 23:2237-2249.
21. Kawase S, K Kuwako, T Imai, F Renault-Mihara, K Yaguchi, S Itohara and H Okano. (2014). Rfx transcription factors control musashi1 transcription in mouse neural stem/progenitor cells. Stem Cells Dev 23:2250-2261.